Coya Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -134.3% | -134.3% | -102.1% |
| FY2022 | 145.9% | 145.9% | -145.8% |
| FY2023 | -22.4% | -22.4% | -19.4% |
| FY2024 | -37.6% | -37.6% | -33.6% |
| FY2025 | -49.3% | -49.3% | -42.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -134.3% | -134.3% | -102.1% |
| FY2022 | 145.9% | 145.9% | -145.8% |
| FY2023 | -22.4% | -22.4% | -19.4% |
| FY2024 | -37.6% | -37.6% | -33.6% |
| FY2025 | -49.3% | -49.3% | -42.5% |